IP Library › Granted Patent US 12,364,479
Granted Patent B2
US 12,364,479 · App. 17/555,683 · Granted Jul 22, 2025

Method of applying a buttress to a surgical stapler

Inventors: Frederick E. Shelton, IV (Hillsboro, OH); Rao S. Bezwada (Whitehouse Station, NJ); Jason L Harris (Lebanon, OH); Prudence A. Turner (Warsaw, IN); Mark S. Zeiner (Mason, OH); Charles J. Scheib (Loveland, OH)
Assignee: Cilag GmbH International
A61B17/105A61B17/068A61B17/07207A61B17/07292A61B2017/00004A61B2017/00951
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,364,479
App. No.
17/555,683
Filed
Dec 20, 2021
Granted
Jul 22, 2025
Kind
B2
Art Unit
3731
USPC
227/177.1
Abstract

A method of applying a buttress to a surgical stapler end effector comprises positioning a buttress assembly between an anvil and a staple cartridge of the end effector. The buttress assembly comprises a buttress body and an adhesive material. The adhesive material faces either an underside of the anvil or a deck of the staple cartridge. The anvil is in an open position relative to the staple cartridge during the act of positioning the buttress assembly between the anvil and the staple cartridge. The method further comprises moving the anvil toward the staple cartridge then moving the anvil back to the open position. The buttress assembly is adhered to the underside of the anvil or the deck of the staple cartridge via the adhesive material with the anvil moved back to the open position. The adhesive material comprises a bioabsorbable polymer.

Claims (41)

1. An apparatus comprising:

(a) a surgical stapling assembly sized and shaped to be supported by a surgical stapler end effector, wherein the surgical stapling assembly comprises:

(i) a deck,

(ii) a plurality of staple pockets formed in the deck, wherein each staple pocket houses a respective staple, and

(iii) a plurality of raised protrusions extending upwardly from the deck, wherein each raised protrusion at least partially surrounds a respective staple pocket, wherein the raised protrusions cooperate to define a recessed deck region of the deck, wherein the recessed deck region includes one or more troughs;

(b) a bioabsorbable adhesive disposed at select locations within the one or more troughs, wherein the raised protrusions are configured to inhibit the bioabsorbable adhesive from entering or overlying the staple pockets, wherein the bioabsorbable adhesive is viscous yet flowable at room temperature; and

(c) a buttress body releasably attached to the deck by the bioabsorbable adhesive.

2. The apparatus of claim 1 , wherein each raised protrusion is configured to contact and thereby guide a staple leg of a respective staple as the staple is ejected outwardly from the respective staple opening.

3. The apparatus of claim 1 , wherein the bioabsorbable adhesive comprises a polymer.

4. The apparatus of claim 3 , wherein the adhesive comprises at least one of polyethylene glycol (PEG) or polyglycolide (PGA).

5. The apparatus of claim 1 , wherein the buttress body is compressible.

6. The apparatus of claim 5 , wherein the buttress body comprises at least one of a fibrous pad, a foam, or a mesh.

7. The apparatus of claim 1 , wherein the surgical stapling assembly comprises a surgical staple cartridge having a cartridge body that defines the deck, wherein the surgical staple cartridge is insertable into a jaw of a surgical stapler end effector.

8. The apparatus of claim 1 , further comprising a film configured to retain the bioabsorbable adhesive during transportation and storage, wherein the film is configured to be peeled away from the deck to expose the bioabsorbable adhesive before the surgical stapling assembly is installed in a surgical stapler end effector.

9. A surgical stapler end effector comprising:

(a) a first jaw that includes the apparatus of claim 1 ; and

(b) a second jaw that includes an anvil having a plurality of staple forming pockets configured to form staples, wherein the first and second jaws are configured to cooperate to clamp, staple, and cut tissue.

10. An apparatus comprising:

(a) a surgical staple cartridge sized and shaped to be inserted into a jaw of a surgical stapler end effector, wherein the surgical staple cartridge comprises:

(i) a cartridge body defining a deck,

(ii) a plurality of staple pockets formed in the deck, wherein each staple pocket houses a respective staple, and

(iii) a plurality of raised protrusions extending upwardly from the deck, wherein each of at least some of the raised protrusions at least partially surrounds a respective staple pocket, wherein the raised protrusions cooperate to define a trough of the deck; and

(b) a buttress assembly, wherein the buttress assembly comprises:

(i) a buttress body, and

(ii) a bioabsorbable adhesive configured to releasably attach the buttress body to the deck of the surgical staple cartridge, wherein the bioabsorbable adhesive is flowable at room temperature and patterned and arranged in a plurality of discrete portions positioned discontinuously upon the buttress body such that the bioabsorbable adhesive is configured to reside within the trough without entering or overlying the staple pockets.

11. The apparatus of claim 10 , wherein each raised protrusion is configured to contact and thereby guide a staple leg of a respective staple as the staple is ejected outwardly from the respective staple opening.

12. The apparatus of claim 10 , wherein the bioabsorbable adhesive is disposed at select locations within the trough.

13. The apparatus of claim 10 , wherein the bioabsorbable adhesive comprises a polymer.

14. The apparatus of claim 13 , wherein the adhesive comprises at least one of polyethylene glycol (PEG) or polyglycolide (PGA).

15. The apparatus of claim 10 , wherein the buttress body is compressible.

16. The apparatus of claim 15 , wherein the buttress body comprises at least one of a fibrous pad, a foam, or a mesh.

17. The apparatus of claim 10 , wherein each of the discrete portions is separate and spaced apart from the remaining discrete portions.

18. A method comprising:

(a) providing a surgical staple cartridge that includes:

(i) a deck having a plurality of staple pockets that house a plurality of staples, and

(ii) a plurality of raised protrusions that extend upwardly from the deck and define a recessed deck region of the deck;

(b) applying a bioabsorbable adhesive to the deck in discrete locations such that the bioabsorbable adhesive resides within the recessed deck region without entering or overlying the staple pockets;

(c) applying a film to the deck so the film contains the bioabsorbable adhesive within the recessed deck region;

(d) removing the film from the deck to expose the bioabsorbable adhesive; and

(e) after removing the film from the deck, releasably securing a buttress body to the deck via the bioabsorbable adhesive.

19. The method of claim 18 , further comprising inserting the surgical staple cartridge into a jaw of a surgical stapler.

Continuity (3)
Continuation 16401234 · May 2, 2019
Continuation 14667842 · Mar 25, 2015
Related Publication 20220175382A1 · Jun 9, 2022
References Cited (133)
US 2642375A · Henderson et al. · 1953 [cited by applicant]
US 4805823A · Rothfuss · 1989 [cited by applicant]
US 5415334A · Williamson et al. · 1995 [cited by applicant]
US 5465895A · Knodel et al. · 1995 [cited by applicant]
US 5597107A · Knodel et al. · 1997 [cited by applicant]
US 5599852A · Scopelianos et al. · 1997 [cited by applicant]
US 5632432A · Schulze et al. · 1997 [cited by applicant]
US 5673840A · Schulze et al. · 1997 [cited by applicant]
US 5686090A · Schilder et al. · 1997 [cited by applicant]
US 5704534A · Huitema et al. · 1998 [cited by applicant]
US 5752965A · Francis et al. · 1998 [cited by applicant]
US 5792135A · Madhani et al. · 1998 [cited by applicant]
US 5814055A · Knodel et al. · 1998 [cited by applicant]
US 5817084A · Jensen · 1998 [cited by applicant]
US 5824333A · Scopelianos et al. · 1998 [cited by applicant]
US 5878193A · Wang et al. · 1999 [cited by applicant]
US 5978921A · Ryu · 1999 [cited by applicant]
US 6231565B1 · Tovey et al. · 2001 [cited by applicant]
US 6355699B1 · Vyakarnam et al. · 2002 [cited by applicant]
US 6364888B1 · Niemeyer et al. · 2002 [cited by applicant]
US 6503257B2 · Grant et al. · 2003 [cited by applicant]
US 6783524B2 · Anderson et al. · 2004 [cited by applicant]
US 6978921B2 · Shelton, IV et al. · 2005 [cited by applicant]
US 7000818B2 · Shelton, IV et al. · 2006 [cited by applicant]
US 7143923B2 · Shelton, IV et al. · 2006 [cited by applicant]
US 7303108B2 · Shelton, IV · 2007 [cited by applicant]
US 7367485B2 · Shelton, IV et al. · 2008 [cited by applicant]
US 7380695B2 · Doll et al. · 2008 [cited by applicant]
US 7380696B2 · Shelton, IV et al. · 2008 [cited by applicant]
US 7404508B2 · Smith et al. · 2008 [cited by applicant]
US 7434715B2 · Shelton, IV et al. · 2008 [cited by applicant]
US 7524320B2 · Tierney et al. · 2009 [cited by applicant]
US 7691098B2 · Wallace et al. · 2010 [cited by applicant]
US 7721930B2 · McKenna et al. · 2010 [cited by applicant]
US 7806891B2 · Nowlin et al. · 2010 [cited by applicant]
US 7950561B2 · Aranyi · 2011 [cited by applicant]
US 8141762B2 · Bedi et al. · 2012 [cited by applicant]
US 8210411B2 · Yates et al. · 2012 [cited by applicant]
US 8308041B2 · Kostrzewski · 2012 [cited by applicant]
US 8371491B2 · Huitema et al. · 2013 [cited by applicant]
US 8408439B2 · Huang et al. · 2013 [cited by applicant]
US 8453904B2 · Eskaros et al. · 2013 [cited by applicant]
US 8453914B2 · Laurent et al. · 2013 [cited by applicant]
US 8479969B2 · Shelton, IV · 2013 [cited by applicant]
US 8573461B2 · Shelton, IV et al. · 2013 [cited by applicant]
US 8573465B2 · Shelton, IV · 2013 [cited by applicant]
US 8602288B2 · Shelton, IV et al. · 2013 [cited by applicant]
US 8616431B2 · Timm et al. · 2013 [cited by applicant]
US 8783541B2 · Shelton, IV et al. · 2014 [cited by applicant]
US 8800838B2 · Shelton, IV · 2014 [cited by applicant]
US 8814025B2 · Miller · 2014 [cited by applicant]
US 8820605B2 · Shelton, IV · 2014 [cited by applicant]
US 8844789B2 · Shelton, IV et al. · 2014 [cited by applicant]
US 8899464B2 · Hueil et al. · 2014 [cited by applicant]
US 8998060B2 · Bruewer et al. · 2015 [cited by applicant]
US 9005243B2 · Stopek et al. · 2015 [cited by applicant]
US 9101359B2 · Smith et al. · 2015 [cited by applicant]
US 9186142B2 · Fanelli et al. · 2015 [cited by applicant]
US 9198644B2 · Balek et al. · 2015 [cited by applicant]
US 9211120B2 · Scheib et al. · 2015 [cited by applicant]
US 9301759B2 · Spivey et al. · 2016 [cited by applicant]
US 9386984B2 · Aronhalt et al. · 2016 [cited by applicant]
US 9393018B2 · Wang et al. · 2016 [cited by applicant]
US 9398911B2 · Auld · 2016 [cited by applicant]
US 9999408B2 · Boudreaux et al. · 2018 [cited by applicant]
US 10349939B2 · Shelton, IV et al. · 2019 [cited by applicant]
US 11369380B2 · Shelton, IV et al. · 2022 [cited by applicant]
US 11779341B2 · Shelton, IV et al. · 2023 [cited by applicant]
US 11832819B2 · Shelton, IV et al. · 2023 [cited by applicant]
US 20020165563A1 · Grant · 2002 [cited by examiner]
US 20050070929A1 · Dalessandro et al. · 2005 [cited by applicant]
US 20080169328A1 · Shelton · 2008 [cited by applicant]
US 20090001122A1 · Prommersberger et al. · 2009 [cited by applicant]
US 20090206143A1 · Huitema et al. · 2009 [cited by applicant]
US 20120187179A1 · Gleiman · 2012 [cited by examiner]
US 20120241492A1 · Shelton, IV et al. · 2012 [cited by applicant]
US 20120241493A1 · Baxter et al. · 2012 [cited by applicant]
US 20120253298A1 · Henderson et al. · 2012 [cited by applicant]
US 20130037596A1 · Bear et al. · 2013 [cited by applicant]
US 20130062391A1 · Boudreaux et al. · 2013 [cited by applicant]
US 20130068816A1 · Vasudevan et al. · 2013 [cited by applicant]
US 20130068820A1 · Miller et al. · 2013 [cited by applicant]
US 20130075447A1 · Weisenburgh et al. · 2013 [cited by applicant]
US 20130153635A1 · Hodgkinson · 2013 [cited by applicant]
US 20130206813A1 · Nalagatla · 2013 [cited by applicant]
US 20140239036A1 · Zerkle et al. · 2014 [cited by applicant]
US 20140239037A1 · Boudreaux et al. · 2014 [cited by applicant]
US 20140239038A1 · Leimbach et al. · 2014 [cited by applicant]
US 20140239040A1 · Fanelli et al. · 2014 [cited by applicant]
US 20140239041A1 · Zerkle et al. · 2014 [cited by applicant]
US 20140239042A1 · Simms et al. · 2014 [cited by applicant]
US 20140239043A1 · Simms et al. · 2014 [cited by applicant]
US 20140239044A1 · Hoffman · 2014 [cited by applicant]
US 20140263563A1 · Stokes et al. · 2014 [cited by applicant]
US 20150136831A1 · Baxter, III · 2015 [cited by applicant]
US 20150272575A1 · Leimbach et al. · 2015 [cited by applicant]
US 20150297235A1 · Harris · 2015 [cited by examiner]
US 20150351754A1 · Harris et al. · 2015 [cited by applicant]
US 20150351763A1 · Shelton, IV et al. · 2015 [cited by applicant]
US 20150374360A1 · Scheib et al. · 2015 [cited by applicant]
US 20150374373A1 · Rector et al. · 2015 [cited by applicant]
US 20160089146A1 · Harris et al. · 2016 [cited by applicant]
US 20160278764A1 · Shelton, IV · 2016 [cited by examiner]
US 20170055981A1 · Vendely et al. · 2017 [cited by applicant]
US 20170367694A1 · Shelton, IV et al. · 2017 [cited by applicant]
US 20230113152A1 · Shelton, IV et al. · 2023 [cited by applicant]
CN 1799650 · 2006 [cited by applicant]
CN 101018572 · 2007 [cited by applicant]
CN 102459408 · 2012 [cited by applicant]
EP 1256317 · 2002 [cited by applicant]
EP 1520525 · 2005 [cited by applicant]
EP 2604196 · 2013 [cited by applicant]
EP 2698118 · 2014 [cited by applicant]
JP 2831439 · 1998 [cited by applicant]
JP 2003524435 · 2003 [cited by applicant]
JP 2005519654 · 2005 [cited by applicant]
JP 2007533796 · 2007 [cited by applicant]
JP 2014121599 · 2014 [cited by applicant]
JP 2015516838 · 2015 [cited by applicant]
WO WO199109079 · 1991 [cited by applicant]
Webster, et al., “PEGylated Proteins: Evaluation of Their Safety in the absence of Definitive Metabolism Studies,” Drug Metabolism and Disposition, 2007, 35(1):9-16. [cited by applicant]
Brazilian Search Report dated Apr. 24, 2020, for Application No. 112017020354-5, 4 pages. [cited by applicant]
Chinese First Office Action dated Oct. 12, 2019, for Application No. 201680030404.2, 12 pages. [cited by applicant]
Chinese Second Office Action and Search Report dated Jun. 23, 2020, for Application No. 201680030404.2, 10 pages. [cited by applicant]
European Partial Search Report dated Jul. 26, 2016, for Application No. 16162067.9, 7 pages. [cited by applicant]
European Communication dated Nov. 16, 2018, for Application No. 16162067.9, 5 pages. [cited by applicant]
European Search Report, Extended, and Written Opinion dated Oct. 31, 2016, for Application No. 16162067.9, 10 pages. [cited by applicant]
European Partial Search Report and Written Opinion dated Sep. 14, 2020, for Application No. 20167229.2, 17 pages. [cited by applicant]
European Search Report and Written Opinion dated Dec. 17, 2020, for Application No. 20167229.2, 15 pages. [cited by applicant]
Indian Search Report dated Oct. 23, 2020, for Application No. 201717032833, 6 pages. [cited by applicant]
International Search Report and Written Opinion dated Oct. 12, 2016, for International Application No. PCT/US2016/023061, 14 pages. [cited by applicant]
Japanese Notification of Reasons for Refusal dated Dec. 13, 2019, for Application No. 2017- 549692, 9 pages. [cited by applicant]
Japanese Final Notification of Reasons for Refusal dated Jun. 16, 2020, for Application No. 2017-549692, 8 pages. [cited by applicant]